Hemophilia A With Inhibitors Recruiting Phase 1 Trials for Coagulation factor VIIa Recombinant Human (DB00036)

Also known as: Hemophilia A With Inhibitor / Haemophilia A With Inhibitors

IndicationStatusPhase
DBCOND0032571 (Hemophilia A With Inhibitors)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04768699Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.Treatment